UK government body considers hip implant registry
This article was originally published in Clinica
A UK engineering testing firm has revealed that it is in discussions with the UK Medical Devices Agency over setting up a register to track the performance of hip implants. The news comes after the MDA warned hospitals throughout the country that 3M Health Care's Capital hip had an unacceptable failure rate, highlighting the need for a method of tracking implant performance (see Clinica No 797, p 17).
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.